9 BioHealth Capital Region Companies That Are Developing Innovative Vaccines and Therapeutics to Combat Global Health Threats

Published on : Published by : Jessica Taaffe, Ph.D.

With diseases like COVID-19, monkeypox, and Ebola, the last few years have highlighted the importance of preparedness and response to global infectious diseases. This includes R&D focused on developing products against current or future global health threats and ongoing R&D efforts aim to expand and improve on these vaccines and therapeutics, developing candidates on different platforms and with better, longer-lasting, or expanded efficacy. Such products can be used during health crises in the US or abroad, to protect and treat travelers, address the burden of infectious diseases that affect many people around the world, and protect against future disease threats in the event of their global spread.

Longhorn’s Universal Influenza Vaccine Candidate LHNVD-105 Shows Promising Strain Coverage

Published on : Published by : BioBuzz Media

Longhorn Vaccines & Diagnostics, LLC (Longhorn), a privately held biotechnology company, today announced publication of pre-clinical data on the company’s universal influenza vaccine candidate, LHNVD-105, which is a multi-epitope unconjugated influenza composite peptide formulated in collaboration with the U.S. Army’s Liposomal Adjuvant (ALFQ). The study, which appears in the June issue of the international, peer-reviewed journal Vaccines, suggests that LHNVD-105 provides broader coverage than seasonal vaccines currently on the market and is less costly to administer and manufacture.

Meet Your 2020 BioBuzz Award Winners

Published on : Published by : Chris Frew

Today, we are excited to announce the winners of our inaugural BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C.

Announcing Finalists for 1st Annual BioBuzz Awards

Published on : Published by : Chris Frew

This year, more than ever before, we’ve seen just how important it is for us all to stay connected and work together to build a stronger biotech ecosystem. In the face of great adversity, the biotech community has risen to the challenge and formed new collaborations and partnerships to innovate and rapidly develop new medicines and tools to help us beat this pandemic.

Maryland’s Longhorn Vaccines & Diagnostics Set to Launch New Product that Could Revolutionize Molecular Testing

Published on : Published by : Steven Surdez

Longhorn Vaccines & Diagnostics, which has offices in Bethesda, Maryland, and San Antonio, Texas, has been at the forefront of the battle against COVID-19. And now, the innovative company has released its latest product, PrimeStore Analyte Transport Media (ATM)Ⓡ, which could revolutionize antigen and molecular testing by completely eliminating the need for RNA and DNA extraction.

Five BioHealth Capital Region Companies Make List of Largest COVID-19 Government Contracts

Five BioHealth Capital Region Companies Make List of Largest COVID-19 Government Contracts
Published on : Published by : Steven Surdez

Five BioHealth Capital Region Companies Make List of Largest COVID-19 Government Contracts At BioBuzz, we’ve been chronicling the BioHealth Capital Region’s contributions to the battle against the coronavirus pandemic. We’ve [….]